Mangkoesoebroto, Arjatya Pramadita
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Kejadian Kardiovaskular Mayor di Rumah Sakit pada Pasien STEMI di Era Pandemi COVID-19 Mangkoesoebroto, Arjatya Pramadita; Herry, Yan; Sofia, Sefri Noventi; Bahrudin, Udin
Medica Hospitalia : Journal of Clinical Medicine Vol. 10 No. 1 (2023): Med Hosp
Publisher : RSUP Dr. Kariadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36408/mhjcm.v10i1.852

Abstract

BACKGROUND: The Coronavirus Disease 2019 (COVID-19) pandemic has become a global burden, changing healthcare system and affecting patients with ST segment elevation myocardial infarction (STEMI). Several countries reported a decrease in hospital admission, changing management, increase total ischemic time, and major cardiovascular events (MACE) in the pandemic era. However, there is limited data especially in Indonesia. OBJECTIVE: To know the differences in admissions, characteristics, management and in-hospital MACE in STEMI patients between pre and pandemic era. METHODS: Comparative observational analytical study was done on 169 patients in the pre-pandemic (12 March 2019-11 March 2020) compared to 163 patients in the pandemic era (12 March 2020-30 September 2021) with STEMI at dr. Kariadi Semarang Hospital. Assessment of monthly admission rates, total ischaemic time, reperfusion management, COVID-19 status and MACE were carried out. RESULTS: During the COVID-19 pandemic, there was a decrease in the average admission of 14.1 to 8.6 patients per month (p<0.001), increase total ischaemic time of 8.78 (3.22-19.68) hours to 10.22 (3 .20-20.43) hours (p<0.001), decreased use of primary PCI (97.0% vs. 83.4%, p<0.001), increased fibrinolytic (1.8% vs8.6%,p=0.010) and no reperfusion (1.2%vs8.0%, p=0.007). There was a significant increase in MACE in the era of the COVID-19 pandemic (10.7%vs22.1%,p=0.008), with mortality (4.7%vs11.7%,p=0.035), stroke (1.2%vs1.8%,p=0.680), cardiogenic shock (4.1%vs11.0%, p=0.030), and acute pulmonary edema (3.6%vs10.4%,p=0.024). CONCLUSION: There was a decrease in admissions and primary PCI procedure, increase use of fibrinolytics and without reperfusion, total ischemic time prolongation, and significant increase of in-hospital MACE in STEMI patients during the COVID-19 pandemic.
Simultaneous Acute Cardio-Cerebral Infarction: A Rare Case Report Experience in Type C Hospital in Indonesia Andriani, Nurlita Asri; Mangkoesoebroto, Arjatya Pramadita; Chairina Yuliandita, Rizkia; Pramudyo, Bayu Hendro
Indonesian Basic and Experimental Health Sciences Vol. 13 No. 2 (2025): APRIL
Publisher : Rumah Sakit Umum Daerah Dr. Moewardi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.11594/ibehs.vol13iss2pp41-47

Abstract

Background: The simultaneous occurrence of ST-elevation myocardial infarction (STEMI) and acute ischemic stroke (AIS) was described as Cardio-Cerebral Infarction. Consequently, we aimed to provide an overview of the available treatment option for patients in type c hospital in order to guide the similar cases. Case Description: A 50-year-old man came to the emergency room complaining of chest pain for two hours before. The patient had a history of hypertension and an active smoker. The patient had a left hemiparesis. The patient's electrocardiogram showed ST segment elevation in leads V3 and V4. A non-contrast head CT-scan showed infarct in the right occipital region. Echocardiogram showed regional wall motion abnormality. The patient was admitted to the hospital, administered DAPT, statin, anticoagulant and discharged after relief of symptoms. Intravenous alteplase followed by primary PCI is the gold standard therapy. However, due to limitation, anticoagulants were chosen and showed clinical improvements. Conclusion: In summary, the goal for treat CCI is to achieve more efficacy therapy while minimising the risk of bleeding. Despite the limitations, patient outcome was good.